sinemet cr 50200 tablet
organon singapore pte. ltd. - carbidopa; levodopa - tablet - 50 mg - carbidopa 50 mg; levodopa 200 mg
sinemet cr
organon pharma israel ltd., israel - carbidopa as monohydrate; levodopa - tablets controlled release - levodopa 200 mg; carbidopa as monohydrate 50 mg - levodopa and decarboxylase inhibitor - idiopathic parkinson's disease. postencephalitic parkinsonism. symptomatic parkinsonism. to reduce "off" time in patients previously treated with levodopa/decarboxylase inhibitor preparations, or with levodopa alone, who have had motor fluctuations characterized by end-of-dose deterioration ("wearing-off" phenomenon), peak dose dyskinesias, akinesia, or similar evidence of short-duration motor disturbances.
sinemet- carbidopa and levodopa tablet
organon llc - carbidopa (unii: mnx7r8c5vo) (carbidopa anhydrous - unii:kr87b45rgh), levodopa (unii: 46627o600j) (levodopa - unii:46627o600j) - sinemet is indicated in the treatment of parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. carbidopa allows patients treated for parkinson's disease to use much lower doses of levodopa. some patients who responded poorly to levodopa have improved on sinemet. this is most likely due to decreased peripheral decarboxylation of levodopa caused by administration of carbidopa rather than by a primary effect of carbidopa on the nervous system. carbidopa has not been shown to enhance the intrinsic efficacy of levodopa. carbidopa may also reduce nausea and vomiting and permit more rapid titration of levodopa. nonselective monoamine oxidase (mao) inhibitors are contraindicated for use with sinemet. these inhibitors must be discontinued at least two weeks prior to initiating therapy with sinemet. sinemet may be administered concomitantly with the manufacturer's recommended dose of an mao inhibitor with selectivity for
stalevo tablet
sandoz canada incorporated - levodopa; carbidopa; entacapone - tablet - 100mg; 25mg; 200mg - levodopa 100mg; carbidopa 25mg; entacapone 200mg - catechol-o-methyltransferase (comt) inhibitors
levodopa-carbidopa cr tablet (extended-release)
pharmascience inc - levodopa; carbidopa - tablet (extended-release) - 100mg; 25mg - levodopa 100mg; carbidopa 25mg - dopamine precursors
mint-levocarb tablet
mint pharmaceuticals inc - levodopa; carbidopa - tablet - 100mg; 10mg - levodopa 100mg; carbidopa 10mg - dopamine precursors
mint-levocarb tablet
mint pharmaceuticals inc - levodopa; carbidopa - tablet - 100mg; 25mg - levodopa 100mg; carbidopa 25mg - dopamine precursors
sinemet plus
merck sharp and dohme limited - levodopa carbidopa - tablets - 25/100 milligram
sinemet plus
imbat limited - levodopa carbidopa - tablets - 25/100 milligram
sinemet 250/25 levodopa/carbidopa 250mg/25mg tablet bottle
merck sharp & dohme (australia) pty ltd - carbidopa monohydrate,levodopa -